OverviewProduct ListData Room


For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution.

Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities.

In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products

DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus


43-10, Techno 5-ro, Yuseong-gu, Daejeon, Korea





CEO  Charlie ParkCorporate #  535-86-00664
Ace Dongbaek Tower 1-1101, 16-4, Dongbaekjungang-ro 16beon-gil, Giheung-gu, Yongin City, Gyeonggido, South Korea    (Post Code 17015)

ⓒ2023 Komachine Inc. All rights reserved.